Tag: Quality Systems

Documenting E&L Failures in Long-Acting Injectables for Regulatory Review As the pharmaceutical industry embraces advanced drug delivery systems such as long-acting injectables, the risk of element and leachables (E&L) failures…

Investigation Into Cpv Trending Gap for Nanoformulations: A Structured Approach to Root Cause Analysis In the realm of pharmaceutical manufacturing, particularly when dealing with advanced nanoformulations, the emergence of gaps…

Documenting OOS Release Profiles Following Formulation Changes: A Guide for Compliance and Investigation In the pharmaceutical manufacturing landscape, deviations such as Out-of-Specification (OOS) results post-formulation change present complex challenges. These…

Addressing Scale-Up Failure Following a Formulation Change: Building a Robust Control Strategy for Inspections In the highly regulated field of pharmaceutical manufacturing, scale-up failures following formulation changes pose significant risks…

Understanding Cpv Trending Gaps Post-Formulation Changes: A Decision-Making Guide for Investigations In pharmaceutical manufacturing, formulation changes are essential for product improvement and adaptation to regulatory requirements. However, they may also…

Addressing Method Transfer Failures in Innovative Delivery Systems: A Regulatory Perspective In the constantly evolving landscape of pharmaceutical manufacturing, method transfer failures can significantly impede the progress of innovative delivery…

Assessing Post-Approval Change Failures in Modified Release Platforms: An Investigation Guide In the fast-evolving landscape of pharmaceutical manufacturing, the introduction of modified release platforms significantly enhances therapeutic efficacy. However, post-approval…